Nicollet Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.48M | Sell |
19,646
-877
| -4% | -$69.2K | 0.51% | 47 |
|
|
2025
Q4 | $1.62M | Buy |
20,523
+115
| +0.6% | +$8.66K | 0.51% | 45 |
|
|
2025
Q3 | $1.33M | Sell |
20,408
-339
| -2% | -$16.6K | 0.44% | 46 |
|
|
2025
Q2 | $820K | Sell |
20,747
-704
| -3% | -$23K | 0.27% | 55 |
|
|
2025
Q1 | $647K | Buy |
21,451
+1,665
| +8% | +$54.5K | 0.23% | 61 |
|
|
2024
Q4 | $692K | Sell |
19,786
-616
| -3% | -$23K | 0.24% | 56 |
|
|
2024
Q3 | $817K | Buy |
20,402
+294
| +1% | +$13.7K | 0.28% | 53 |
|
|
2024
Q2 | $958K | Sell |
20,108
-413
| -2% | -$16.9K | 0.36% | 47 |
|
|
2024
Q1 | $890K | Buy |
20,521
+10,745
| +110% | +$512K | 0.33% | 53 |
|
|
2023
Q4 | $495K | Buy |
9,776
+1,108
| +13% | +$53.1K | 0.2% | 55 |
|
|
2023
Q3 | $393K | Sell |
8,668
-90
| -1% | -$3.71K | 0.18% | 55 |
|
|
2023
Q2 | $359K | Buy |
8,758
+293
| +3% | +$11.3K | 0.16% | 56 |
|
|
2023
Q1 | $303K | Buy |
8,465
+527
| +7% | +$19.8K | 0.16% | 55 |
|
|
2022
Q4 | $300K | Sell |
7,938
-570
| -7% | -$24K | 0.17% | 55 |
|
|
2022
Q3 | $376K | Buy |
8,508
+66
| +0.8% | +$2.78K | 0.21% | 51 |
|
|
2022
Q2 | $313K | Buy |
8,442
+173
| +2% | +$6.52K | 0.17% | 52 |
|
|
2022
Q1 | $306K | Sell |
8,269
-235
| -3% | -$7.69K | 0.14% | 55 |
|
|
2021
Q4 | $259K | Sell |
8,504
-1,997
| -19% | -$62.9K | 0.1% | 58 |
|
|
2021
Q3 | $352K | Sell |
10,501
-3
| -0% | -$113 | 0.15% | 56 |
|
|
2021
Q2 | $419K | Sell |
10,504
-307
| -3% | -$12K | 0.17% | 60 |
|
|
2021
Q1 | $486K | Sell |
10,811
-58
| -0.5% | -$3.23K | 0.21% | 58 |
|
|
2020
Q4 | $615K | Buy |
10,869
+508
| +5% | +$25.3K | 0.28% | 52 |
|
|
2020
Q3 | $492K | Sell |
10,361
-29
| -0.3% | -$1.61K | 0.25% | 50 |
|
|
2020
Q2 | $613K | Buy |
10,390
+385
| +4% | +$21.4K | 0.34% | 48 |
|
|
2020
Q1 | $473K | Sell |
10,005
-335
| -3% | -$18.7K | 0.35% | 49 |
|
|
2019
Q4 | $625 | Sell |
10,340
-290
| -3% | -$17.3K | 0.29% | 55 |
|
|
2019
Q3 | $637K | Buy |
10,630
+75
| +0.7% | +$4.89K | 0.4% | 54 |
|
|
2019
Q2 | $678K | Sell |
10,555
-70
| -0.7% | -$4.95K | 0.43% | 49 |
|
|
2019
Q1 | $862K | Buy |
10,625
+30
| +0.3% | +$1.94K | 0.57% | 48 |
|
|
2018
Q4 | $573K | Sell |
10,595
-95
| -0.9% | -$4.84K | 0.45% | 52 |
|
|
2018
Q3 | $551K | Buy |
10,690
+435
| +4% | +$20.4K | 0.36% | 61 |
|
|
2018
Q2 | $427K | Buy |
10,255
+330
| +3% | +$14.6K | 0.31% | 61 |
|
|
2018
Q1 | $437K | Buy |
9,925
+30
| +0.3% | +$1.52K | 0.34% | 61 |
|
|
2017
Q4 | $498K | Buy |
+9,895
| New | +$543K | 0.41% | 59 |
|
Other funds holding IONS
VPM
VCM
Nicollet Investment Management's IONS Position: Q1 2026 in Review
Nicollet Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 4.3% in Q1 2026, selling an estimated $69.2K and leaving 19,646 shares worth $1.48M. The position accounts for 0.51% of the portfolio, ranked #47.
Nicollet Investment Management first reported a position in IONS in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.62M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Nicollet Investment Management held 19,646 shares of Ionis Pharmaceuticals worth $1.48M as of Q1 2026.
- Nicollet Investment Management sold 877 Ionis Pharmaceuticals shares in Q1 2026, an estimated $69.2K.
- Ionis Pharmaceuticals made up 0.51% of Nicollet Investment Management's portfolio in Q1 2026, its #47 holding.
- Nicollet Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
- Nicollet Investment Management's Ionis Pharmaceuticals position peaked at $1.62M in Q4 2025.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Nicollet Investment Management's 13F filing for Q1 2026, filed 13 May 2026.